U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
CILGAVIMAB
INN   USAN  
Official Name English
COV2-2130
Code English
AZD1061
Code English
CILGAVIMAB [JAN]
Common Name English
IMMUNOGLOBULIN G1 (248-THREONINE,249-METHIONINE,316-TYROSINE,318-THREONINE,320-GLUTAMIC ACID), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL AZD1061 .GAMMA.1-CHAIN), DISULFIDE WITH HUM
Common Name English
cilgavimab [INN]
Common Name English
AZD-1061
Code English
Cilgavimab [WHO-DD]
Common Name English
CILGAVIMAB [USAN]
Common Name English
Code System Code Type Description
RXCUI
2587306
Created by admin on Sat Dec 16 17:11:16 GMT 2023 , Edited by admin on Sat Dec 16 17:11:16 GMT 2023
PRIMARY
NCI_THESAURUS
C177058
Created by admin on Sat Dec 16 17:11:16 GMT 2023 , Edited by admin on Sat Dec 16 17:11:16 GMT 2023
PRIMARY
CAS
2420563-99-9
Created by admin on Sat Dec 16 17:11:16 GMT 2023 , Edited by admin on Sat Dec 16 17:11:16 GMT 2023
PRIMARY
SMS_ID
300000026511
Created by admin on Sat Dec 16 17:11:16 GMT 2023 , Edited by admin on Sat Dec 16 17:11:16 GMT 2023
PRIMARY
INN
11777
Created by admin on Sat Dec 16 17:11:16 GMT 2023 , Edited by admin on Sat Dec 16 17:11:16 GMT 2023
PRIMARY
DAILYMED
1KUR4BN70F
Created by admin on Sat Dec 16 17:11:16 GMT 2023 , Edited by admin on Sat Dec 16 17:11:16 GMT 2023
PRIMARY
USAN
JK-65
Created by admin on Sat Dec 16 17:11:16 GMT 2023 , Edited by admin on Sat Dec 16 17:11:16 GMT 2023
PRIMARY
FDA UNII
1KUR4BN70F
Created by admin on Sat Dec 16 17:11:16 GMT 2023 , Edited by admin on Sat Dec 16 17:11:16 GMT 2023
PRIMARY
ACTIVE MOIETY
CILGAVIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966